Status:
UNKNOWN
Registry for Advanced Sarcodiosis
Lead Sponsor:
University of Cincinnati
Conditions:
Sarcoidosis
Eligibility:
All Genders
15-100 years
Brief Summary
Registry with evaluation and genetic information of patients with advanced sarcoidosis and matched sarcoidosis
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patients with diagnosis of sarcoidosis based on ATS/WASOG criteria 22
- Age ≥ 18 years.
- Life expectancy of at least 2 years.
- Pulmonary function tests (spirometry) within one month of entry or willing to under pulmonary function testing on the day of study enrollment
- Sarcoidosis as characterized as either advanced or non-advanced (see protocol for definition of advanced disease)
- Subjects must be able to understand and be willing to sign the written informed consent form. A signed informed consent form must be appropriately obtained prior to the conduct of any trial-specific procedure.
- Exclusion criteria
- Subjects with a medical disorder, condition, or history of such that would impair the subject's ability to participate or complete this study in the opinion of the investigator
- Inability to comply with the protocol and/or not willing or not available for follow-up assessments.
- Any condition which, in the investigator's opinion, makes the subject unsuitable for trial participation.
Exclusion
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2020
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT03769987
Start Date
January 1 2017
End Date
June 30 2020
Last Update
December 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cincinnati
Cincinnati, Ohio, United States, 45267